Biggest News Aggregation in the World
📰 Clinformatics Data Mart Database News

Clinformatics Data Mart Database News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Clinformatics Data Mart Database. Real-time updates on events, politics, business and more.

Kidney Stone Risk Lower With SGLT2 Inhibitor vs Other Diabetes Drug Classes

The association between SGLT2i use and kidney stone risk was similar by race and ethnicity, sex, obesity, and history of chronic kidney disease. Use of an SGLT2 inhibitor instead of other classes of glucose-lowering agents is associated with lower kidney stone risk.
United States Juliem Paik Clinformatics Data Mart Database Medicare Fee For Service Parts

Kidney Stone Risk Lower With SGLT2 Inhibitor vs Other Diabetes Drug Classes

Adult patients with type 2 diabetes (T2D) who use a sodium-glucose cotransporter 2 inhibitor (SGLT2i) rather than other classes of glucose-lowering agents Use of an SGLT2 inhibitor instead of other classes of glucose-lowering agents is associated with lower kidney stone risk.
United States Juliem Paik Clinformatics Data Mart Database Medicare Fee For Service Parts

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

SGLT2i Use Linked to Lower Risk of Nephrolithiasis in Patients With Type 2 Diabetes

Compared to glucagon-like peptide 1 receptor agonists and dipeptidyl peptidase 4 inhibitors, Use of sodium-glucose cotransporter 2 inhibitors was linked to a decreased risk of nephrolithiasis in patients with type 2 diabetes.
Julie Paik Us Centers For Disease Centers For Disease Harvard Medical School Women Hospital Harvard Medical School Julie Paik Disease Control

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science